IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Century Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.47+0.10 (+7.30%)
Close on Oct 19, 2026
- Market cap
- $302.49M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
87.3%
158M of 181M shares
Institutional holders
99
37 new, 10 sold out
Net institutional buying
19M
In Q2 2026
Insider trades, 12 months
3 buys · 20 sales
Net bought $10.95K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 5,961,563 | 6.80% | 13G (passive) amendment | Dec 23, 2025 |
| Boxer Capital, LLC | 4,901,603 | 5.80% | 13G (passive) | Apr 15, 2024 |
| Point72 Capital Advisors, Inc. | 4,725,639 | 5.40% | 13G (passive) | Dec 23, 2025 |
| RA Capital Management, L.P. | 17,944,649 | 9.90% | 13G (passive) | Jan 9, 2026 |
| Chen Yu | 17,754,430 | 9.90% | 13G (passive) | Jan 9, 2026 |
| Deep Track Capital, LP | 13,486,400 | 7.34% | 13G (passive) | Jan 8, 2026 |
| Commodore Capital Master LP | 13,043,478 | 7.10% | 13G (passive) | Jan 9, 2026 |
| Nimish Shah | 13,043,478 | 7.10% | 13G (passive) | Jan 9, 2026 |
| Roderick Wong | 13,043,478 | 7.10% | 13G (passive) | Mar 31, 2026 |
| Versant Venture Capital VI, L.P. | 11,452,014 | 19.10% | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IPSC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 17,754,430 | 9.80% | $43.50M | – | 0.38% |
| TCG Crossover Management, LLC | 17,754,430 | 9.80% | $43.40M | – | 1.04% |
| Versant Venture Management, LLC | 12,166,109 | 6.72% | $29.81M | – | 18.33% |
| Deep Track Capital, LP | 9,462,645 | 5.23% | $23.18M | −25,100 | 0.34% |
| Rtw Investments, LP | 8,695,652 | 4.80% | $21.30M | – | 0.18% |
| VR Adviser, LLC | 8,695,652 | 4.80% | $21.30M | – | 0.65% |
| Commodore Capital LP | 8,695,652 | 4.80% | $21.30M | – | 1.27% |
| BlackRock, Inc. | 8,091,768 | 4.47% | $19.82M | +6,567,346 | 0.00% |
| Vanguard Capital Management LLC | 5,703,680 | 3.15% | $13.97M | +17,476 | 0.00% |
| Balyasny Asset Management L.P. | 5,522,944 | 3.05% | $13.53M | +505,211 | 0.02% |
| Point72 Asset Management, L.P. | 4,980,526 | 2.75% | $12.20M | −984,152 | 0.01% |
| Seven Fleet Capital Management LP | 4,347,826 | 2.40% | $10.65M | +1,400,000 | 1.76% |
| Woodline Partners LP | 4,257,530 | 2.35% | $10.43M | +1,214,052 | 0.03% |
| Millennium Management LLC | 4,194,981 | 2.32% | $10.28M | −472,082 | 0.00% |
| Trails Edge Capital Partners, LP | 4,134,969 | 2.28% | $10.13M | +1,684,976 | 1.61% |
| Spruce Street Capital LP | 4,059,054 | 2.24% | $9.94M | – | 1.95% |
| Adage Capital Partners Gp, L.L.C. | 3,789,538 | 2.09% | $9.28M | – | 0.01% |
| Geode Capital Management, LLC | 2,979,529 | 1.65% | $7.30M | +1,677,865 | 0.00% |
| Two Sigma Investments, LP | 2,699,013 | 1.49% | $6.61M | +327,583 | 0.00% |
| DAFNA Capital Management LLC | 2,400,458 | 1.33% | $5.88M | −33,895 | 1.12% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 99 | 158M | 87.3% | 37 / 29 | 12 / 10 | 23M | 4M |
| Q1 2026 | 72 | 139M | 76.6% | 32 / 16 | 11 / 6 | 120M | 4M |
| Q4 2025 | 47 | 26M | 14.2% | 8 / 8 | 15 / 16 | 12M | 7M |
| Q3 2025 | 57 | 20M | 11.2% | 5 / 10 | 28 / 13 | 2M | 5M |
| Q2 2025 | 65 | 23M | 12.5% | 21 / 15 | 21 / 26 | 5M | 12M |
| Q1 2025 | 70 | 30M | 16.3% | 7 / 16 | 29 / 8 | 1M | 7M |
| Q4 2024 | 72 | 36M | 20.1% | 15 / 30 | 10 / 10 | 6M | 10M |
| Q3 2024 | 67 | 40M | 21.9% | 12 / 20 | 16 / 5 | 7M | 5M |
| Q2 2024 | 61 | 40M | 22.2% | 7 / 32 | 14 / 13 | 20M | 3M |
| Q1 2024 | 67 | 24M | 13.0% | 14 / 17 | 21 / 10 | 7M | 1M |
| Q4 2023 | 63 | 18M | 9.9% | 15 / 23 | 18 / 7 | 2M | 2M |
| Q3 2023 | 55 | 18M | 10.0% | 4 / 17 | 20 / 13 | 0M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of IPSC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 4,339,806 | 2.40% | $10.63M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 2,900,660 | 1.60% | $7.11M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,343,126 | 0.74% | $2.71M | 0.01% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1,222,691 | 0.68% | $3.00M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 1,106,934 | 0.61% | $2.71M | 0.02% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 560,308 | 0.31% | $1.37M | 0.00% | May 31, 2026 |
| Small Cap Value Fund | 549,930 | 0.30% | $1.35M | 0.20% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 413,323 | 0.23% | $1.01M | 0.07% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 299,452 | 0.17% | $604.89K | 0.01% | Jul 31, 2026 |
| Master Small Cap Index Series | 230,383 | 0.13% | $564.44K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 200,453 | 0.11% | $491.11K | 0.00% | May 31, 2026 |
| Fidelity Small Cap Value Index Fund | 172,406 | 0.10% | $422.39K | 0.02% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 164,276 | 0.09% | $402.48K | 0.00% | May 31, 2026 |
| Nuveen Small Cap Blend Index Fund | 163,592 | 0.09% | $330.46K | 0.01% | Jul 31, 2026 |
| EQ/2000 Managed Volatility Portfolio | 131,018 | 0.07% | $320.99K | 0.01% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Brent Pfeiffenberger | President and CEO, Director | 3,633,839 | 2.01% | Sep 15, 2026 |
| Gregory Russotti | See Remarks | 601,971 | 0.33% | Sep 15, 2026 |
| Douglas Carr | SVP Finance & Operations | 502,907 | 0.28% | Sep 15, 2026 |
| Chad Cowan | Chief Scientific Officer | 1,186,019 | 0.65% | Jun 15, 2026 |
| Adrienne Farid | Chief Operations Officer | 250,141 | 0.14% | Jun 11, 2025 |
| Morgan Conn | Chief Finanical Officer | 79,648 | 0.04% | Mar 12, 2025 |
| Joseph Truitt | Director | – | – | Sep 10, 2026 |
| Martin Patrick Murphy | Director | – | – | Jun 12, 2026 |
| Kimberly Blackwell | Director | – | – | Jun 12, 2026 |
| Alessandro Riva | Director | – | – | Jun 12, 2026 |
| Daphne Quimi | Director | 5,000 | 0.00% | Jun 12, 2026 |
| Han Myung Lee | Director | – | – | Jun 12, 2026 |
| Cynthia M. Butitta | Director | 98,936 | 0.05% | Jun 16, 2025 |
| Timothy P. Walbert | Director | – | – | Jun 16, 2025 |
| Rizzuto Carlo | Director | – | – | Jun 16, 2025 |
| Joseph Jimenez | Director | 494,346 | 0.27% | Jun 16, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gregory Russotti See Remarks | Sep 14, 2026 | Sale | −2,587 | $1.93 | $4.99K | 509,198 |
| Douglas Carr SVP Finance & Operations | Sep 14, 2026 | Sale | −1,658 | $1.93 | $3.20K | 502,907 |
| Brent Pfeiffenberger President and CEO, Director | Sep 11, 2026 | Tax withholding | −13,850 | $1.94 | $26.87K | 3,633,839 |
| Douglas Carr SVP Finance & Operations | Sep 8, 2026 | Sale | −254 | $2.05 | $521 | 504,565 |
| Gregory Russotti See Remarks | Sep 8, 2026 | Sale | −534 | $2.05 | $1.09K | 511,785 |
| Brent Pfeiffenberger President and CEO, Director | Sep 4, 2026 | Tax withholding | −463 | $2.11 | $977 | 3,633,839 |
| Brent Pfeiffenberger President and CEO, Director | Aug 14, 2026 | Tax withholding | −31,172 | $1.92 | $59.85K | 3,634,302 |
| Douglas Carr SVP Finance & Operations | Aug 3, 2026 | Sale | −275 | $1.98 | $545 | 504,819 |
| Douglas Carr SVP Finance & Operations | Jun 12, 2026 | Sale | −1,654 | $2.23 | $3.69K | 505,094 |
| Gregory Russotti See Remarks | Jun 12, 2026 | Sale | −2,584 | $2.23 | $5.76K | 512,319 |
| Chad Cowan Chief Scientific Officer | Jun 11, 2026 | Tax withholding | −358 | $2.24 | $802 | 1,175,322 |
| Brent Pfeiffenberger President and CEO, Director | Jun 11, 2026 | Tax withholding | −13,849 | $2.24 | $31.02K | 3,665,474 |
| Douglas Carr SVP Finance & Operations | Jun 8, 2026 | Sale | −249 | $2.11 | $525 | 506,748 |
| Gregory Russotti See Remarks | Jun 8, 2026 | Sale | −524 | $2.11 | $1.11K | 514,903 |
| Brent Pfeiffenberger President and CEO, Director | Jun 5, 2026 | Tax withholding | −463 | $2.13 | $986 | 3,679,323 |
| Brent Pfeiffenberger President and CEO, Director | May 15, 2026 | Tax withholding | −31,172 | $2.34 | $72.94K | 3,679,786 |
| Douglas Carr SVP Finance & Operations | May 4, 2026 | Sale | −264 | $2.34 | $618 | 506,997 |
| Chad Cowan Chief Scientific Officer | Apr 1, 2026 | Tax withholding | −1,365 | $2.19 | $2.99K | 1,175,680 |
| Douglas Carr SVP Finance & Operations | Mar 12, 2026 | Sale | −7,043 | $2.55 | $17.96K | 507,261 |
| Gregory Russotti See Remarks | Mar 12, 2026 | Sale | −10,076 | $2.55 | $25.69K | 515,427 |
| Chad Cowan Chief Scientific Officer | Mar 11, 2026 | Tax withholding | −1,431 | $2.73 | $3.91K | 1,177,045 |
| Brent Pfeiffenberger President and CEO, Director | Mar 11, 2026 | Tax withholding | −55,397 | $2.73 | $151.23K | 3,710,958 |
| Gregory Russotti See Remarks | Mar 9, 2026 | Sale | −479 | $2.54 | $1.22K | 525,503 |
| Douglas Carr SVP Finance & Operations | Mar 9, 2026 | Sale | −247 | $2.54 | $627 | 514,304 |
| Brent Pfeiffenberger President and CEO, Director | Mar 6, 2026 | Tax withholding | −463 | $2.56 | $1.19K | 3,766,355 |
| Brent Pfeiffenberger President and CEO, Director | Feb 13, 2026 | Tax withholding | −31,172 | $1.75 | $54.55K | 3,766,818 |
| Douglas Carr SVP Finance & Operations | Feb 3, 2026 | Sale | −323 | $1.82 | $588 | 514,551 |
| Douglas Carr SVP Finance & Operations | Feb 2, 2026 | Award | +110,000 | – | – | 514,874 |
| Brent Pfeiffenberger President and CEO, Director | Feb 2, 2026 | Award | +475,000 | – | – | 3,797,990 |
| Chad Cowan Chief Scientific Officer | Feb 2, 2026 | Award | +135,000 | – | – | 1,178,476 |
| Gregory Russotti See Remarks | Feb 2, 2026 | Award | +135,000 | – | – | 525,982 |
| Chad Cowan Chief Scientific Officer | Jan 2, 2026 | Tax withholding | −1,611 | $1.00 | $1.61K | 1,043,476 |
| Chad Cowan Chief Scientific Officer | Dec 22, 2025 | Buy | +58,060 | $0.85 | $49.35K | 1,045,087 |
| Brent Pfeiffenberger President and CEO, Director | Dec 12, 2025 | Buy | +52,000 | $0.58 | $30.16K | 3,322,990 |
| Brent Pfeiffenberger President and CEO, Director | Dec 10, 2025 | Tax withholding | −463 | $0.53 | $245 | 3,270,990 |
| Douglas Carr SVP Finance & Operations | Dec 8, 2025 | Sale | −257 | $0.53 | $136 | 404,874 |
| Gregory Russotti See Remarks | Dec 8, 2025 | Sale | −526 | $0.53 | $279 | 390,982 |
| Chad Cowan Chief Scientific Officer | Nov 20, 2025 | Sale | −5,462 | $0.50 | $2.73K | 987,027 |
| Brent Pfeiffenberger President and CEO, Director | Nov 19, 2025 | Buy | +35,000 | $0.50 | $17.50K | 3,271,453 |
| Brent Pfeiffenberger President and CEO, Director | Nov 17, 2025 | Sale | −32,456 | $0.45 | $14.61K | 3,236,453 |
| Douglas Carr SVP Finance & Operations | Nov 3, 2025 | Sale | −292 | $0.59 | $172 | 405,131 |
| Chad Cowan Chief Scientific Officer | Sep 18, 2025 | Award | +762,543 | – | – | 992,489 |
| Douglas Carr SVP Finance & Operations | Sep 8, 2025 | Sale | −263 | $0.50 | $132 | 405,423 |
| Gregory Russotti See Remarks | Sep 8, 2025 | Sale | −539 | $0.50 | $270 | 391,508 |
| Brent Pfeiffenberger President and CEO, Director | Sep 8, 2025 | Sale | −488 | $0.50 | $244 | 3,268,909 |
| Brent Pfeiffenberger President and CEO, Director | Aug 14, 2025 | Award | +1,587,614 | – | – | 3,269,397 |
| Douglas Carr SVP Finance & Operations | Aug 4, 2025 | Sale | −296 | $0.53 | $157 | 405,686 |
| Adrienne Farid Chief Operations Officer | Jun 9, 2025 | Sale | −552 | $0.62 | $342 | 250,141 |
| Douglas Carr SVP Finance & Operations | Jun 9, 2025 | Sale | −4,904 | $0.62 | $3.04K | 405,982 |
| Brent Pfeiffenberger President and CEO, Director | Jun 9, 2025 | Sale | −475 | $0.62 | $295 | 1,681,783 |
| Gregory Russotti See Remarks | Jun 9, 2025 | Sale | −526 | $0.62 | $326 | 392,047 |
| Brent Pfeiffenberger President and CEO, Director | May 16, 2025 | Sale | −29,552 | $0.55 | $16.25K | 1,682,258 |
| Adrienne Farid Chief Operations Officer | May 5, 2025 | Sale | −1,024 | $0.55 | $563 | 250,693 |
| Douglas Carr SVP Finance & Operations | May 5, 2025 | Sale | −295 | $0.55 | $162 | 410,886 |
| Douglas Carr SVP Finance & Operations | Mar 11, 2025 | Award | +95,625 | – | – | 411,181 |
| Gregory Russotti See Remarks | Mar 11, 2025 | Award | +120,000 | – | – | 392,573 |
| Brent Pfeiffenberger President and CEO, Director | Mar 11, 2025 | Award | +521,500 | – | – | 1,711,810 |
| Chad Cowan Chief Scientific Officer | Mar 11, 2025 | Award | +19,500 | – | – | 230,306 |
| Adrienne Farid Chief Operations Officer | Mar 11, 2025 | Award | +120,000 | – | – | 251,717 |
| Morgan Conn Chief Finanical Officer | Mar 11, 2025 | Award | +19,500 | – | – | 79,648 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Gregory Russotti Officer | Sep 14, 2026 | 2,587 | $4.99K | Sep 14, 2026 | Restricted Stock Vesting |
| Douglas Carr Officer | Sep 14, 2026 | 1,658 | $3.20K | Sep 14, 2026 | Restricted Stock Vesting |
| Gregory Russotti Officer | Sep 8, 2026 | 534 | $1.09K | Sep 8, 2026 | Restricted Stock Vesting |
| Gregory Russotti Officer | Jun 12, 2026 | 2,584 | $5.77K | Jun 12, 2026 | Restricted Stock Vesting |
| Gregory Russotti Officer | Jun 8, 2026 | 524 | $1.11K | Jun 8, 2026 | Restricted Stock Vesting |
| Gregory Russotti Officer | Mar 12, 2026 | 10,076 | $25.69K | Mar 12, 2026 | Restricted Stock Vesting |
| Gregory Russotti Officer | Mar 9, 2026 | 479 | $1.21K | Mar 9, 2026 | Restricted Stock Vesting |
| Brent Pfeiffenberger Officer, Director | Dec 9, 2025 | 0 | $0 | Dec 8, 2025 | Restricted Stock Vesting |
| Brent Pfeiffenberger Officer, Director | Dec 8, 2025 | 476 | $253 | Dec 8, 2025 | Restricted Stock Vesting |
| Gregory Russotti Officer | Dec 8, 2025 | 526 | $280 | Dec 8, 2025 | Restricted Stock Vesting |
| Chad Cowan Officer | Nov 20, 2025 | 5,462 | $2.74K | Nov 20, 2025 | Restricted Stock Vesting |
| Brent Pfeiffenberger Officer, Director | Nov 17, 2025 | 32,456 | $14.73K | Nov 17, 2025 | Restricted Stock Vesting |
| Brent Pfeiffenberger Officer, Director | Sep 8, 2025 | 488 | $244 | Sep 8, 2025 | Restricted Stock Vesting |
| Gregory Russotti Officer | Sep 8, 2025 | 539 | $269 | Sep 8, 2025 | Restricted Stock Vesting |
| Brent Pfeiffenberger Officer, Director | Aug 18, 2025 | 30,745 | $17.52K | Aug 18, 2025 | Restricted Stock Vesting |